On this page

ToDAY®

Cephapirin Sodium

Veterinary NADA Approved 860 adverse event reports

Overview

Source: Animal Drugs @ FDA
Proprietary name
ToDAY®
Active ingredient
Cephapirin Sodium
Application type
NADA
Sponsor
Boehringer lngelheim Animal Health USA, Inc.
Applications on record
1
First published
July 31, 2025

Adverse event reports

Source: openFDA VeDDRA
860
Reports mentioning this ingredient
January 29, 1987 – March 16, 2026
113
Classified serious
per reporter assessment
115
Lack of expected efficacy
resistance signal
3
Human operator exposure
needle-stick or splash
Not a risk measure. Veterinary adverse event reports are influenced by how many animals are treated, reporting practice and product age. Reports do not establish that the product caused the event, and a single report can cover an entire herd or flock. Attribution here is by active ingredient because the source dataset redacts brand names.

Attributed by active ingredient “CEPHAPIRIN SODIUM”. Green Book ingredient names and VeDDRA ingredient names do not always agree exactly, so attribution is approximate and labelled as such.

Reported reactions

Source: openFDA VeDDRA

Clinical signs coded in the VICH VeDDRA four-level hierarchy, most frequent first.

Reaction terms reported for this ingredient, by report count.
Reaction (VeDDRA term) Reports Relative frequency
Residues in milk 581
Drug dose administration interval too long 74
INEFFECTIVE, ANTIBIOTIC 51
Lack of efficacy (bacteria) - NOS 50
Tubes, Damaged 26
Tubes, Leaking 22
Tubes, Abnormal 20
Containers, Damaged 19
Product Defect, General 16
Product syringe issue 16
Lack of efficacy - NOS 12
Caps, Abnormal 11
Underfilling, Package 10
Dispenser, Abnormal 9
Product problem 9
Drug administration duration too long 9
Mastitis NOS 8
Uncoded sign 8
Syringe, Abnormal 8
Death 7

Species affected

Source: openFDA VeDDRA
Cattle 722 Goat 5 Horse 3 Human 1 Dog 1 Sheep 1

Regulatory context

New Animal Drug Application (NADA). A pioneer approval evaluated for target animal safety, therapeutic effectiveness, manufacturing controls and — for food-producing species — human food safety including residue depletion.

Extra-label use in food-producing animals is governed by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) and 21 CFR Part 530. It requires a valid veterinarian-client-patient relationship and is prohibited outright for certain drug classes. Withdrawal times are determined by FARAD, not by this index.

Sources for this page

Animal Drugs @ FDA FDA CVM Applications, sponsor, status, withdrawal
Animal & Veterinary Events FDA CVM VeDDRA adverse event aggregates by active ingredient